Point-of-Care PCR Assays for COVID-19 Detection

Molecular diagnostics has been the front runner in the world’s response to the COVID-19 pandemic. Particularly, reverse transcriptase-polymerase chain reaction (RT-PCR) and the quantitative variant (qRT-PCR) have been the gold standard for COVID-19 diagnosis. However, faster antigen tests and other...

Full description

Bibliographic Details
Main Authors: Niharika Gupta, Shine Augustine, Tarun Narayan, Alan O’Riordan, Asmita Das, D. Kumar, John H. T. Luong, Bansi D. Malhotra
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/11/5/141
_version_ 1797535515472297984
author Niharika Gupta
Shine Augustine
Tarun Narayan
Alan O’Riordan
Asmita Das
D. Kumar
John H. T. Luong
Bansi D. Malhotra
author_facet Niharika Gupta
Shine Augustine
Tarun Narayan
Alan O’Riordan
Asmita Das
D. Kumar
John H. T. Luong
Bansi D. Malhotra
author_sort Niharika Gupta
collection DOAJ
description Molecular diagnostics has been the front runner in the world’s response to the COVID-19 pandemic. Particularly, reverse transcriptase-polymerase chain reaction (RT-PCR) and the quantitative variant (qRT-PCR) have been the gold standard for COVID-19 diagnosis. However, faster antigen tests and other point-of-care (POC) devices have also played a significant role in containing the spread of SARS-CoV-2 by facilitating mass screening and delivering results in less time. Thus, despite the higher sensitivity and specificity of the RT-PCR assays, the impact of POC tests cannot be ignored. As a consequence, there has been an increased interest in the development of miniaturized, high-throughput, and automated PCR systems, many of which can be used at point-of-care. This review summarizes the recent advances in the development of miniaturized PCR systems with an emphasis on COVID-19 detection. The distinct features of digital PCR and electrochemical PCR are detailed along with the challenges. The potential of CRISPR/Cas technology for POC diagnostics is also highlighted. Commercial RT–PCR POC systems approved by various agencies for COVID-19 detection are discussed.
first_indexed 2024-03-10T11:45:49Z
format Article
id doaj.art-f974efce97094c34b2677b68d9d21f9b
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-10T11:45:49Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-f974efce97094c34b2677b68d9d21f9b2023-11-21T18:08:16ZengMDPI AGBiosensors2079-63742021-05-0111514110.3390/bios11050141Point-of-Care PCR Assays for COVID-19 DetectionNiharika Gupta0Shine Augustine1Tarun Narayan2Alan O’Riordan3Asmita Das4D. Kumar5John H. T. Luong6Bansi D. Malhotra7Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Delhi 110042, IndiaDepartment of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Delhi 110042, IndiaNanotechnology Group, Tyndall National Institute, University College Cork, T12 K8AF Cork, IrelandNanotechnology Group, Tyndall National Institute, University College Cork, T12 K8AF Cork, IrelandDepartment of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Delhi 110042, IndiaDepartment of Applied Chemistry, Delhi Technological University, Shahbad Daulatpur, New Delhi 110042, IndiaSchool of Chemistry, University College Cork, T12 K8AF Cork, IrelandDepartment of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Delhi 110042, IndiaMolecular diagnostics has been the front runner in the world’s response to the COVID-19 pandemic. Particularly, reverse transcriptase-polymerase chain reaction (RT-PCR) and the quantitative variant (qRT-PCR) have been the gold standard for COVID-19 diagnosis. However, faster antigen tests and other point-of-care (POC) devices have also played a significant role in containing the spread of SARS-CoV-2 by facilitating mass screening and delivering results in less time. Thus, despite the higher sensitivity and specificity of the RT-PCR assays, the impact of POC tests cannot be ignored. As a consequence, there has been an increased interest in the development of miniaturized, high-throughput, and automated PCR systems, many of which can be used at point-of-care. This review summarizes the recent advances in the development of miniaturized PCR systems with an emphasis on COVID-19 detection. The distinct features of digital PCR and electrochemical PCR are detailed along with the challenges. The potential of CRISPR/Cas technology for POC diagnostics is also highlighted. Commercial RT–PCR POC systems approved by various agencies for COVID-19 detection are discussed.https://www.mdpi.com/2079-6374/11/5/141polymerase chain reactionCOVID-19electrochemicaldigital PCRpoint-of-care
spellingShingle Niharika Gupta
Shine Augustine
Tarun Narayan
Alan O’Riordan
Asmita Das
D. Kumar
John H. T. Luong
Bansi D. Malhotra
Point-of-Care PCR Assays for COVID-19 Detection
Biosensors
polymerase chain reaction
COVID-19
electrochemical
digital PCR
point-of-care
title Point-of-Care PCR Assays for COVID-19 Detection
title_full Point-of-Care PCR Assays for COVID-19 Detection
title_fullStr Point-of-Care PCR Assays for COVID-19 Detection
title_full_unstemmed Point-of-Care PCR Assays for COVID-19 Detection
title_short Point-of-Care PCR Assays for COVID-19 Detection
title_sort point of care pcr assays for covid 19 detection
topic polymerase chain reaction
COVID-19
electrochemical
digital PCR
point-of-care
url https://www.mdpi.com/2079-6374/11/5/141
work_keys_str_mv AT niharikagupta pointofcarepcrassaysforcovid19detection
AT shineaugustine pointofcarepcrassaysforcovid19detection
AT tarunnarayan pointofcarepcrassaysforcovid19detection
AT alanoriordan pointofcarepcrassaysforcovid19detection
AT asmitadas pointofcarepcrassaysforcovid19detection
AT dkumar pointofcarepcrassaysforcovid19detection
AT johnhtluong pointofcarepcrassaysforcovid19detection
AT bansidmalhotra pointofcarepcrassaysforcovid19detection